The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
Open accessAbstract
bacteremia occurred after they had undergone FMT in two independent clinical trials; both cases were linked to the same stool donor by means of genomic sequencing. One of the patients died. Enhanced donor screening to limit the transmission of microorganisms that could lead to adverse infectious events and continued vigilance to define the benefits and risks of FMT across different patient populations are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FMT may also carry the risk of unintended introduction of pathogens and antibiotic-resistant microbes into the recipients.749,750”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [749]
In the citing paper
“In 2019, it was reported that in two independent clinical trials, two patients developed bacteremia with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli after receiving FMT from the same donor, and one patient died [136].”
From Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies (2022) · cites this paper as [136]
In the citing paper
“This issue has become extremely timely after the transmission of an extended-spectrum b -lactamase-producing Escherichia coli strain from a stool donor to two immunocompromised recipients who developed bacteremia, with a fatal outcome in one case. 46”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [46]
In the citing paper
“Indeed, two cases of MDR bacteria transmission with life-threatening complications have been described in patients with cirrhosis and hematological malignancy after repeated FMT. 46”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [46]
In the citing paper
“Although FMT is generally recognized as safe, with no or limited side effects,33 unexpected toxicity has been reported, e.g., extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli bacteremia in two patients who received FMT.34”
From Faecalibacterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors (2024) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1085 · Cited by 2,690
European consensus conference on faecal microbiota transplantation in clinical practice
Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313017 · Cited by 1,207
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C. P., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy149 · Cited by 1,163
Beceiro, A., Tomás, M., & Bou, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-12 · Cited by 1,118
Kassam, Z., Lee, C. H., Yuan, Y., & Hunt, R. H. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.59 · Cited by 904
Pathological bacterial translocation in liver cirrhosis
Wiest, R., Lawson, M. A., & Geuking, M. B. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.044 · Cited by 826
Youngster, I., Russell, G. H., Pindar, C., Ziv-Baran, T., Sauk, J., & Hohmann, E. L. (2014) · JAMA · doi:10.1001/jama.2014.13875 · Cited by 629
Self-citationSchürch, A. C., Arredondo-Alonso, S., Willems, R. J. L., & Goering, R. V. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.12.016 · Cited by 534
Mullish, B. H., Quraishi, M. N., Segal, J. P., McCune, V. L., Baxter, M., Marsden, G. L., Moore, D., Colville, A., Bhala, N. B., Iqbal, T. H., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-316818 · Cited by 344
Research works printed but not linked: 1
- Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: CLSI supplement M100. 29th ed. Wayne, PA: Clinical and Laboratory Standards Institute, 2019.
Cited by
Sorted by citations
Items 101–200 of 1,000
Sharma, A., Roy, A., Premkumar, M., Verma, N., Duseja, A. K., Taneja, S., Grover, S., Chopra, M., & Dhiman, R. K. (2022) · Hepatology International · doi:10.1007/s12072-022-10312-z · Cited by 110
Haifer, C., Kelly, C. R., Paramsothy, S., Andresen, D. N., Papanicolas, L. E., McKew, G. L., Borody, T. J., Kamm, M. A., Costello, S. P., Andrews, J. M., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-320260 · Cited by 108
Sepsis and the Microbiome: A Vicious Cycle
Miller, W. D., Keskey, R. C., & Alverdy, J. C. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa682 · Cited by 106
Xu, H., Cao, C., Ren, Y., Weng, S., Liu, L., Guo, C., Wang, L., Han, X., Ren, J., & Liu, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.949490 · Cited by 110
Saha, S., Mara, K. C., Pardi, D. S., & Khanna, S. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.01.010 · Cited by 103
Mamic, P., Chaikijurajai, T., & Tang, W. H. W. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.12.001 · Cited by 100
Shiga Toxin–Producing Escherichia coli Transmission via Fecal Microbiota Transplant
Zellmer, C., Sater, M. R. A., Huntley, M. H., Osman, M., Olesen, S. W., & Ramakrishna, B. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1486 · Cited by 98
Self-citationDietary and Microbial Determinants in Food Allergy
Victor, E. S., Crestani, E., & Chatila, T. A. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.025 · Cited by 101
Fecal microbiota transplantation: Emerging applications in autoimmune diseases
Yang, R., Chen, Z., & Cai, J. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103038 · Cited by 103
Selective targeting of skin pathobionts and inflammation with topically applied lactobacilli
Lebeer, S., Oerlemans, E. F. M., Claes, I., Henkens, T., Delanghe, L., Wuyts, S., Spacova, I., van den Broek, M. F. L., Tuyaerts, I., Wittouck, S., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100521 · Cited by 95
Microbiome therapeutics for hepatic encephalopathy
Bloom, P. P., Tapper, E. B., Young, V. B., & Lok, A. S.-F. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.08.004 · Cited by 96
Self-citationInamura, K., Hamada, T., Bullman, S., Ugai, T., Yachida, S., & Ogino, S. (2022) · Gut · doi:10.1136/gutjnl-2022-327209 · Cited by 97
The Next Generation Fecal Microbiota Transplantation: To Transplant Bacteria or Virome
Yu, Y., Wang, W., & Zhang, F. (2023) · Advanced Science · doi:10.1002/advs.202301097 · Cited by 105
Investiture of next generation probiotics on amelioration of diseases – Strains do matter
Lin, T., Shu, C.-C., Lai, W.-F., Tzeng, C., Lai, H., & Lu, C. (2019) · Medicine in Microecology · doi:10.1016/j.medmic.2019.100002 · Cited by 101
Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases
Hou, S., Yu, J., Li, Y., Zhao, D., & Zhang, Z. (2025) · Advanced Science · doi:10.1002/advs.202413197 · Cited by 97
The Gut–CNS Axis in Multiple Sclerosis
Kadowaki, A., & Quintana, F. J. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.06.002 · Cited by 95
The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease
Huang, Y., Xin, W., Xiong, J., Yao, M., Zhang, B., & Zhao, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.837500 · Cited by 93
Prospects for probiotics in social bees
Motta, E. V. S., Powell, J. E., Leonard, S. P., & Moran, N. A. (2022) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2021.0156 · Cited by 92
A cross-systems primer for synthetic microbial communities
Mehlferber, E. C., Arnault, G., Joshi, B., Partida‐Martínez, L. P., Patras, K. A., Simonin, M., & Koskella, B. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01827-2 · Cited by 94
Ballerini, M., Galié, S., Tyagi, P., Catozzi, C., Raji, H., Nabinejad, A., Macandog, A. D. G., Cordiale, A., Slivinschi, B. I., Kugiejko, K. K., et al. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01318-z · Cited by 98
Elkrief, A., Pidgeon, R., Vareki, S. M., Messaoudene, M., Castagner, B., & Routy, B. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01211-7 · Cited by 99
Bajaj, J. S., Salzman, N. H., Acharya, C., Takei, H., Kakiyama, G., Fagan, A., White, M. B., Gavis, E. A., Holtz, M. L., Hayward, M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.133410 · Cited by 91
Bile acid-independent protection against Clostridioides difficile infection
Aguirre, A. M., Yalçınkaya, N., Wu, Q., Swennes, A. G., Tessier, M. E. M., Roberts, P., Miyajima, F., Savidge, T., & Sorg, J. A. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010015 · Cited by 95
Next‐Generation Probiotics: Microflora Intervention to Human Diseases
Zhang, H., Duan, Y., Cai, F., Cao, D., Wang, L., Qiao, Z., Hong, Q., Li, N., Zheng, Y., Su, M., et al. (2022) · BioMed Research International · doi:10.1155/2022/5633403 · Cited by 99
An ecological framework to understand the efficacy of fecal microbiota transplantation
Xiao, Y., Angulo, M. T., Lao, S., Weiss, S. T., & Liu, Y.-Y. (2020) · Nature Communications · doi:10.1038/s41467-020-17180-x · Cited by 89
Melanoma and microbiota: Current understanding and future directions
Routy, B., Jackson, T., Mählmann, L., Baumgartner, C. K., Blaser, M., Byrd, A., Corvaia, N., Couts, K., Davar, D., Derosa, L., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2023.12.003 · Cited by 89
Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome
Mishima, Y., & Ishihara, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228664 · Cited by 94
Langdon, A. E., Schwartz, D. J., Bulow, C., Sun, X., Hink, T., Reske, K. A., Jones, C. R., Burnham, C. D., Dubberke, E. R., & Dantas, G. A. (2021) · Genome Medicine · doi:10.1186/s13073-021-00843-9 · Cited by 90
A framework for microbiome science in public health
Wilkinson, J. E., Franzosa, E. A., Everett, C., Li, C., trainees, H. R. A., Bae, S., Berzansky, I., Bhosle, A., Bjørnevik, K., Brennan, C. A., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01258-0 · Cited by 92
Recent Advances in Understanding the Structure and Function of the Human Microbiome
Mousa, W. K., Chehadeh, F., & Husband, S. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.825338 · Cited by 91
Lou, X., Xue, J., Shao, R., Yang, Y., Ning, D., Mo, C., Wang, F., & Chen, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1063543 · Cited by 87
Nicco, C., Paule, A., Konturek, P. C., & Edeas, M. A. (2020) · Diseases · doi:10.3390/diseases8020009 · Cited by 91
Yadegar, A., Pakpour, S., Ibrahim, F. F., Nabavi-Rad, A., Cook, L. E., Walter, J., Seekatz, A. M., Wong, K., Monaghan, T. M., & Kao, D. H. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.03.019 · Cited by 90
El‐Salhy, M., Winkel, R., Casèn, C., Hausken, T., Gilja, O. H., & Hatlebakk, J. G. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.06.020 · Cited by 84
Fecal Microbiota Transplantation for Dysbiosis — Predictable Risks
Blaser, M. J. (2019) · New England Journal of Medicine · doi:10.1056/nejme1913807 · Cited by 86
Therapies to modulate gut microbiota: Past, present and future
Gupta, A., Saha, S., & Khanna, S. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i8.777 · Cited by 84
Bajaj, J. S., Shamsaddini, A., Fagan, A., Sterling, R. K., Gavis, E. A., Khoruts, A., Fuchs, M. A., Lee, H., Sikaroodi, M., & Gillevet, P. M. (2020) · Hepatology Communications · doi:10.1002/hep4.1639 · Cited by 83
Orenstein, R., Dubberke, E. R., Khanna, S., Lee, C., Yoho, D. S., Johnson, S., Hecht, G. A., DuPont, H. L., Gerding, D. N., Blount, K., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07256-y · Cited by 83
Functional Restoration of Bacteriomes and Viromes by Fecal Microbiota Transplantation
Fujimoto, K., Kimura, Y., Allegretti, J. R., Yamamoto, M., Zhang, Y., Katayama, K., Tremmel, G., Kawaguchi, Y., Shimohigoshi, M., Hayashi, T., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.02.013 · Cited by 85
Engineering the gut microbiome
Bai, X., Huang, Z., Duraj‐Thatte, A., Ebert, M., Zhang, F., Burgermeister, E., Liu, X., Scott, B. M., Li, G., & Zuo, T. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00072-2 · Cited by 85
Kao, D., Wong, K., Franz, R., Cochrane, K., Sherriff, K., Chui, L., Lloyd, C., Roach, B., Bai, A. D., Petrof, E. O., et al. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00007-8 · Cited by 81
Magruder, M. L., Edusei, E., Zhang, L., Albakry, S., Satlin, M. J., Westblade, L. F., Malha, L. P., Sze, C., Lubetzky, M., Dadhania, D. M., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1805281 · Cited by 83
The role of the microbiota in the management of intensive care patients
Szychowiak, P., Villageois-Tran, K., Patrier, J., Timsit, J., & Ruppé, É. (2022) · Annals of Intensive Care · doi:10.1186/s13613-021-00976-5 · Cited by 86
Chains of evidence from correlations to causal molecules in microbiome-linked diseases
Chaudhari, S. N., McCurry, M. D., & Devlin, A. S. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00861-z · Cited by 82
Recent FDA Approvals in the Treatment of Graft-Versus-Host Disease
Martini, D. J., Chen, Y., & DeFilipp, Z. M. (2022) · The Oncologist · doi:10.1093/oncolo/oyac076 · Cited by 84
Self-citationGut microbiome in gastrointestinal cancer: a friend or foe?
Liu, Y., Baba, Y., Ishimoto, T., Gu, X. J., Zhang, J., Nomoto, D., Okadome, K., Baba, H., & Qiu, P. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.69331 · Cited by 82
Microbiota therapeutics for inflammatory bowel disease: the way forward
Bethlehem, L., Estevinho, M. M., Grinspan, A. M., Magro, F., Faith, J. J., & Colombel, J. (2024) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(23)00441-7 · Cited by 85
Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure
Uribe‐Herranz, M., Klein-González, N., Rodríguez‐Lobato, L. G., Juan, M., & de Larrea, C. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031026 · Cited by 84
Seekatz, A. M., Safdar, N., & Khanna, S. (2022) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848221134396 · Cited by 84
Campos-Madueno, E. I., Moradi, M., Eddoubaji, Y., Shahi, F., Moradi, S., Bernasconi, O. J., Moser, A. I., & Endimiani, A. (2023) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-023-04548-2 · Cited by 79
Fecal microbiota transplantation: no longer cinderella in tumour immunotherapy
Yang, Y., An, Y., Dong, Y., Chu, Q., Wei, J., Wang, B., & Cao, H. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.104967 · Cited by 84
Shen, A. (2020) · Annual Review of Microbiology · doi:10.1146/annurev-micro-011320-011321 · Cited by 83
Acharya, C., & Bajaj, J. S. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.10.056 · Cited by 79
Gut microbiota and sepsis: from pathogenesis to novel treatments
Kullberg, R. F. J., Wiersinga, W. J., & Haak, B. W. (2021) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000781 · Cited by 78
Fecal Microbiota Transplantation: The Evolving Risk Landscape
Gupta, S., Mullish, B. H., & Allegretti, J. R. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001075 · Cited by 76
Bloom, P. P., Donlan, J., Soto, M. T., Daidone, M., Hohmann, E. L., & Chung, R. T. (2022) · Hepatology Communications · doi:10.1002/hep4.1950 · Cited by 76
Self-citationFang, H., Fang, M., Wang, Y., Zhang, H., Li, J., Chen, J., Wu, Q., He, L., Xu, J., Deng, J. H., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00125-22 · Cited by 76
Microbiota Transplant in the Treatment of Obesity and Diabetes: Current and Future Perspectives
Napolitano, M., & Covașă, M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.590370 · Cited by 76
Zhao, Y., Li, X., Zhou, Y., Gao, J., Jiao, Y., Zhu, B., Wu, D., & Qi, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.678476 · Cited by 76
The heightened importance of the microbiome in cancer immunotherapy
Villemin, C., Six, A., Neville, B. A., Lawley, T. D., Robinson, M. J., & Bakdash, G. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.11.002 · Cited by 81
The central role of the gut in intensive care
Corriero, A., Gadaleta, R. M., Puntillo, F., Inchingolo, F., Moschetta, A., & Brienza, N. (2022) · Critical Care · doi:10.1186/s13054-022-04259-8 · Cited by 78
Translating eco-evolutionary biology into therapy to tackle antibiotic resistance
Sanz‐García, F., Gil‐Gil, T., Laborda, P., Blanco, P., Ochoa-Sánchez, L. E., Baquero, F., Martínez, J. L., & Hernando‐Amado, S. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00902-5 · Cited by 81
Faecalibacterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors
Bredon, M., Danne, C., Pham, H. P., Ruffié, P., Bessede, A., Rolhion, N., Creusot, L., Brot, L., Alonso, I., Langella, P., et al. (2024) · OncoImmunology · doi:10.1080/2162402x.2024.2374954 · Cited by 74
Zhao, H., Zhou, Y., Xu, J., Zhang, Y., Wang, H., Zhao, C., Huang, H., Yang, J., Huang, C.-T., Li, Y., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05122-w · Cited by 76
Lin, A., Jiang, A., Huang, L., Yu, H., Zhang, C., Zhu, L., Mou, W., Liu, Z., Zhang, J., Cheng, Q., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2452277 · Cited by 74
Xie, C., Qi, C., Zhang, J., Wang, W., Meng, X., Aikepaer, A., Lin, Y., Su, C., Liu, Y., Feng, X., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116791 · Cited by 74
A review of gut failure as a cause and consequence of critical illness
Soranno, D. E., Coopersmith, C. M., Brinkworth, J. F., Factora, F. N., Muntean, J. H., Mythen, M. G., Raphael, J., Shaw, A., Vachharajani, V., & Messer, J. S. (2025) · Critical Care · doi:10.1186/s13054-025-05309-7 · Cited by 77
Zhang, L. R., Wang, Y., Wu, F., Wang, X., Feng, Y., & Wang, Y. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.12.036 · Cited by 73
Liu, C. S., Monaghan, T. M., Yadegar, A., Louie, T., & Kao, D. H. (2023) · Antibiotics · doi:10.3390/antibiotics12071141 · Cited by 73
Arab, J. P., Arrese, M. A., & Shah, V. H. (2019) · Hepatology Research · doi:10.1111/hepr.13473 · Cited by 76
Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation
Sun, J., Song, S., Liu, J., Chen, F., Li, X., & Wu, G. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00678-x · Cited by 78
Roles of the intestinal microbiota and microbial metabolites in acute GVHD
Lin, D., Hu, B., Li, P., Zhao, Y., Xu, Y., & Wu, D. (2021) · Experimental Hematology & Oncology · doi:10.1186/s40164-021-00240-3 · Cited by 71
The microbiome in rheumatology: Where are we and where should we go?
Manasson, J., Blank, R. B., & Scher, J. U. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216631 · Cited by 73
Li, X., Song, Y., Wang, L., Kang, G., Wang, P., Yin, H., & Huang, H. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.660431 · Cited by 71
Multidrug-Resistant Gram-Negative Bacteria
Mills, J., & Marchaim, D. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.08.001 · Cited by 71
Fecal Microbiota Transplantation and Other Gut Microbiota Manipulation Strategies
Quaranta, G., Guarnaccia, A., Fancello, G., Agrillo, C., Iannarelli, F., Sanguinetti, M., & Masucci, L. (2022) · Microorganisms · doi:10.3390/microorganisms10122424 · Cited by 72
Huang, H., Wang, Q., Yang, Y., Zhong, W., He, F., & Li, . (2024) · Gut Microbes · doi:10.1080/19490976.2024.2440111 · Cited by 74
Postbiotic-Enabled Targeting of the Host-Microbiota-Pathogen Interface: Hints of Antibiotic Decline?
Puccetti, M., Xiroudaki, S., Ricci, M., & Giovagnoli, S. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070624 · Cited by 59
Gut microbiome in pediatric acute leukemia: from predisposition to cure
Masetti, R., Muratore, E., Leardini, D., Zama, D., Turroni, S., Brigidi, P., Esposito, S., & Pession, A. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005129 · Cited by 71
The role of the gut microbiota in tumor, immunity, and immunotherapy
Xie, Y., & Liu, F. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1410928 · Cited by 75
The Link between Gut Microbiota and Hepatic Encephalopathy
Won, S., Oh, K., Gupta, H., Ganesan, R., Sharma, S. P., Jeong, J., Yoon, S. J., Jeong, M. K., Min, B. H., Hyun, J. Y., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168999 · Cited by 69
Recent advances in modulating the microbiome
Quigley, E. M. M., & Gajula, P. (2020) · F1000Research · doi:10.12688/f1000research.20204.1 · Cited by 69
Integrating Systems and Synthetic Biology to Understand and Engineer Microbiomes
Leggieri, P. A., Liu, Y., Hayes, M. M., Connors, B., Seppälä, S., O’Malley, M., & Venturelli, O. S. (2021) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-082120-022836 · Cited by 70
Stool Banking for Fecal Microbiota Transplantation: Methods and Operations at a Large Stool Bank
Chen, J., Zaman, A., Ramakrishna, B., OpenBiome Team, & Olesen, S. W. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.622949 · Cited by 68
Yang, Y., Zhou, X., Chan, Y. K., Wang, Z., Li, L., Li, J., Liang, K., & Deng, Y. (2022) · Small · doi:10.1002/smll.202105988 · Cited by 68
Čierniková, S., Ševčíková, A., Drgoňa, Ľ., & Mego, M. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188990 · Cited by 68
Odenwald, M. A., Lin, H., Lehmann, C. J., Dylla, N. P., Cole, C. G., Mostad, J. D., Pappas, T. E., Ramaswamy, R., Moran, A., Hutchison, A. L., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01493-w · Cited by 69
Microbiota transplant for hepatic encephalopathy in cirrhosis: The THEMATIC trial
Bajaj, J. S., Fagan, A., Gavis, E. A., Sterling, R. K., Gallagher, M. L., Lee, H. M., Matherly, S. C., Siddiqui, M. S., Bartels, A., Mousel, T., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2024.12.047 · Cited by 68
Gonzales-Luna, A. J., Carlson, T. J., & Garey, K. W. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2223345 · Cited by 67
Zikou, E., Koliaki, C. C., & Makrilakis, K. (2024) · Biomedicines · doi:10.3390/biomedicines12081871 · Cited by 68
Antibiotic-related gut dysbiosis induces lung immunodepression and worsens lung infection in mice
Dessein, R., Bauduin, M., Grandjean, T., Guern, R. L., Figeac, M., Beury, D., Faure, K., Faveeuw, C., Guery, B. P., Gosset, P., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03320-8 · Cited by 69
Encapsulated Fecal Microbiota Transplantation: Development, Efficacy, and Clinical Application
Halaweish, H., Boatman, S. M., & Staley, C. M. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.826114 · Cited by 74
Fecal microbiota transplantation in the metabolic diseases: Current status and perspectives
Zheng, L., Ji, Y.-Y., Wen, X., & Duan, S.-L. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i23.2546 · Cited by 69
Gut Microbiome Modulates Response to Cancer Immunotherapy
Khan, M. A. W., Ologun, G. O., Arora, R., McQuade, J. L., & Wargo, J. A. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06111-x · Cited by 69
Terveer, E. M., Vendrik, K. E. W., Ooijevaar, R. E., van Lingen, E., Boeije‐Koppenol, E., van Nood, E., Goorhuis, A., Bauer, M. P., van Beurden, Y. H., Dijkgraaf, M. G. W., et al. (2020) · United European Gastroenterology Journal · doi:10.1177/2050640620957765 · Cited by 68
McQuade, J. L., Ologun, G. O., Arora, R., & Wargo, J. A. (2020) · Current Oncology Reports · doi:10.1007/s11912-020-00913-y · Cited by 63
Raman‐activated sorting of antibiotic‐resistant bacteria in human gut microbiota
Wang, Y., Xu, J., Kong, L., Li, B., Li, H., Huang, W. E., & Zheng, C. (2020) · Environmental Microbiology · doi:10.1111/1462-2920.14962 · Cited by 63
Targeting the Gut Microbiome to Mitigate Immunotherapy-Induced Colitis in Cancer
Chang, A. E., Golob, J. L., Schmidt, T. M., Peltier, D. C., Lao, C. D., & Tewari, M. (2021) · Trends in Cancer · doi:10.1016/j.trecan.2021.02.005 · Cited by 62
Wang, N., Wu, S., Huang, L., Hu, Y., He, X., He, J., Hu, B., Xu, Y., Rong, Y., Yuan, C., et al. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01117-x · Cited by 62
Kwak, S., Choi, J., Hink, T., Reske, K. A., Blount, K., Jones, C. R., Bost, M. H., Sun, X., Burnham, C. D., Dubberke, E. R., et al. (2020) · Microbiome · doi:10.1186/s40168-020-00907-9 · Cited by 62
Metadata
- Authors
- DeFilipp, Z., Bloom, P. P., Torres Soto, M., Mansour, M. K., Sater, M. R. A., Huntley, M. H., Turbett, S., Chung, R. T., Chen, Y.-B., & Hohmann, E. L.
- Affiliations
- Harvard University (US)
- From the Blood and Marrow Transplant Program (Z.D., Y.-B.C.), the Liver Center, Division of Gastroenterology (P.P.B., R.T.C.), and the Division of Infectious Diseases (M.T.S., M.K.M., S.T., E.L.H.), Massachusetts General Hospital, Harvard Medical School (Z.D., P.P.B., M.T.S., M.K.M., S.T., R.T.C., Y.-B.C., E.L.H.), and Day Zero Diagnostics (M.R.A.S., M.H.H.) — all in Boston.
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2019-11-21
- Volume
- 381
- Issue
- 21
- Pages
- 2043-2050
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2982566732
- Cited by
- 1,281
- References
- 26
- Citations by year
- 2026: 202 · 2025: 160 · 2024: 158 · 2023: 175 · 2022: 169 · 2021: 184 · 2020: 222 · 2019: 10
- FWCI
- 112.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Massachusetts General Hospital
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- drug-resistant Escherichia coli, bacteremia, fecal microbiota transplantation, donor screening, genome sequencing
- MeSH terms
- Fecal Microbiota Transplantation, Aged, beta-Lactamases, Escherichia coli, Feces, Hepatic Encephalopathy, Humans, Male, Myelodysplastic Syndromes, Bacteremia, Fatal Outcome, Drug Resistance, Bacterial, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
